Cardiac resynchronization therapy for patients with cardiac sarcoidosis.

about

Cardiac resynchronization therapy for patients with cardiac sarcoidosis.

Item

http://www.wikidata.org/entity/Q38878994

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cardiac resynchronization therapy for patients with cardiac sarcoidosis.

@en

type

Item

label

Cardiac resynchronization therapy for patients with cardiac sarcoidosis.

@en

prefLabel

Cardiac resynchronization therapy for patients with cardiac sarcoidosis.

@en

P1476

Cardiac resynchronization therapy for patients with cardiac sarcoidosis.

@en

P2093

Akinori Sairaku

http://www.w3.org/2001/XMLSchema#string

Haruki Hashimoto

http://www.w3.org/2001/XMLSchema#string

Haruo Hirayama

http://www.w3.org/2001/XMLSchema#string

Mayuho Maeda

http://www.w3.org/2001/XMLSchema#string

Yasuki Kihara

http://www.w3.org/2001/XMLSchema#string

Yukihiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Yukiko Nakano

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.

Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations.

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.

Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.

Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.

Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization.

Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

P304

824-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EUROPACE/EUW223

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28339577

http://www.w3.org/2001/XMLSchema#string